Retefuse 18mg Injection
Marketer
Lupin Ltd
Salt Composition
Reteplase (18mg)
Overview Retefuse 18mg Injection
Thrombolysis with the 18mg Retefuse Injection involves dissolving blood clots obstructing blood vessels, a critical intervention for acute myocardial infarction (heart attack). This thrombolytic agent, also known as a "clot buster," rapidly restores blood flow to ischemic tissue, thereby limiting damage. Administered intravenously by a physician immediately upon presentation of heart attack symptoms, Retefuse necessitates close monitoring of vital signs including respiration, blood pressure, and oxygen saturation. Concurrent or subsequent anticoagulant therapy is often employed. Increased bleeding risk necessitates caution with activities involving sharp objects. Potential side effects include nausea, vomiting, hypotension, and injection site hemorrhage. Retefuse requires expert administration and is contraindicated in numerous situations, particularly those involving recent head trauma, cerebrospinal surgery, or any active bleeding. Comprehensive medical history review is mandatory prior to treatment.
Primary Ingredients of Retefuse 18mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Retefuse 18mg Injection
Myocardial infarction
Major Benefits of Retefuse 18mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Retefuse 18mg Injection:
- Bleeding disorder
- Nausea
- Vomiting
- Decreased blood pressure
- Injection site bleeding
How to use Retefuse 18mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Retefuse 18mg Injection works:
Thrombolytic agent Retefuse, administered via 18mg injection, disintegrates damaging blood clots within blood vessels. This action restores circulation to compromised tissue, mitigating tissue necrosis and enhancing patient prognosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Retefuse 18mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Retefuse 18mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Retefuse 18mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingNOT RELEVANT
Retefuse 18mg Injection is restricted to inpatient administration.
KidneyCAUTION
Caution is advised when administering Retefuse 18mg Injection to individuals with impaired kidney function; dosage modification may be necessary. Physician consultation is recommended. Retefuse 18mg Injection is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should receive Retefuse 18mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Retefuse 18mg Injection is contraindicated in patients exhibiting severe renal dysfunction.
What if you forget to take Retefuse 18mg Injection :
NA
Facts to Know About Retefuse 18mg Injection
| Label | Value |
|---|---|
| Chemical Category | Carboxylic Acid Derivatives |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Thrombolytic Agents (Plasminogen Activators) |
3,018 People bought this recently